Rashid, M ORCID: https://orcid.org/0000-0001-9725-1583, Wu, J, Timmis, A, Curzen, N, Clarke, S, Zaman, A, Nolan, J, Shoaib, A ORCID: https://orcid.org/0000-0003-0513-8319, Mohamed, MO ORCID: https://orcid.org/0000-0002-9678-5222, de Belder, MA, Deanfield, J, Gale, CP and Mamas, MA ORCID: https://orcid.org/0000-0001-9241-8890 (2021) Outcomes of COVID-19 Positive Acute Coronary Syndrome Patients; a multisource Electronic Healthcare Records Study from England. Journal of Internal Medicine.

[img]
Preview
Text
joim.13246.pdf - Accepted Version

Download (12MB) | Preview

Abstract

BACKGROUND: Patients with underlying cardiovascular disease and Coronavirus disease 2019 (COVID-19) infection are at increased risk of morbidity and mortality. OBJECTIVES: This study was designed to characterise the presenting profile and outcomes of patients hospitalized with acute coronary syndrome (ACS) and COVID-19 infection. METHODS: This observational cohort study was conducted using multisource data from all acute NHS hospitals in England. All consecutive patients hospitalized with diagnosis of ACS with or without COVID-19 infection between 1st March- 31st May 2020 were included. The primary outcome was in-hospital and 30-day mortality. RESULTS: A total of 12,958 patients were hospitalized with ACS during the study period, of which 517 (4.0%) were COVID-19 positive and were more likely to present with non-ST elevation acute myocardial infarction. COVID-19 ACS group were generally older, Black Asian and Minority ethnicity, more comorbid and had unfavourable presenting clinical characteristics such as elevated cardiac troponin, pulmonary oedema, cardiogenic shock and poor left ventricular systolic function compared with non-COVID-19 ACS group. They were less likely to receive an invasive coronary angiography (67.7% vs 81.0%), percutaneous coronary intervention (PCI) (30.2% vs 53.9%) and dual antiplatelet medication (76.3% vs 88.0%). After adjusting for all the baseline differences, patients with COVID-19 ACS had higher in-hospital (adjusted odds ratio (aOR) 3.27 95% confidence interval (CI) 2.41-4.42) and 30-day mortality (aOR 6.53 95%CI 5.1-8.36) compared to the non COVID-19 ACS group. CONCLUSION: COVID-19 infection was present in 4% of patients hospitalized with an ACS in England and is associated with lower rates of guideline recommended treatment and significant mortality hazard.

Item Type: Article
Additional Information: The final version of this Gold Open Access article and all relevant information can be found online at; https://onlinelibrary.wiley.com/doi/10.1111/joim.13246
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
R Medicine > RC Internal medicine > RC666 Diseases of the circulatory (Cardiovascular) system
Divisions: Faculty of Medicine and Health Sciences > School of Primary, Community and Social Care
Related URLs:
Depositing User: Symplectic
Date Deposited: 05 Feb 2021 08:48
Last Modified: 05 Feb 2021 08:48
URI: https://eprints.keele.ac.uk/id/eprint/9129

Actions (login required)

View Item View Item